Biotech and healthcare trusts came at the top of performance tables in NAV terms in February, as the sector continues to “claw back losses” suffered prior to the US election, according to investment trust analysts QuotedData.
read more here
Biotech and healthcare trusts came at the top of performance tables in NAV terms in February, as the sector continues to “claw back losses” suffered prior to the US election, according to investment trust analysts QuotedData.
read more here